ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With Inhibitors on Concizumab Prophylaxis: Results From the Phase 3 explorer7 Study

0 views
December 28, 2022
Comments 0
Login to view comments. Click here to Login